Morten Hylander Møller

Morten Hylander Møller

Auto-generated profile, based on publicly available information

Morten Hylander Møller

Department of Intensive Care Copenhagen University Hospital—Rigshospitalet Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
AGAnders Granholm
Anders Granholm
WAWaleed Alhazzani
Waleed Alhazzani
MMMorten H. Møller
Morten H. Møller

10 April 2015 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MKMette Krag
Mette Krag
APAnders Perner
Anders Perner
JWJørn Wetterslev
Jørn Wetterslev
MWMatt P. Wise
Matt P. Wise
MBMark Borthwick
Mark Borthwick
MMMorten Hylander Møller
Morten Hylander Møller

10 June 2013 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
DBD L Buck
D L Buck
MVM Vester-Andersen
M Vester-Andersen
MMM H Møller
M H Møller
Background: Morbidity and mortality following perforated peptic ulcer (PPU) remain substantial. Surgical delay is a well established negative prognostic factor, but evidence derives from studies with a high risk of bias. The aim of the present nationwide cohort study was to evaluate the adjusted effect of hourly surgical delay on survival after PPU. Methods: This was a cohort study including all Danish patients treated surgically for PPU between 1 February 2003 and 31 August 2009. Medically treated patients and those with a malignant ulcer were excluded. The associations between surgical delay and 30-day survival are presented as crude and adjusted relative risks (RRs) with 95 per cent confidence intervals (c.i.). Results: A total of 2668 patients were included. Their median age was 70·9 (range 16·2–104·2) years and 55·4 per cent (1478 of 2668) were female. Some 67·5 per cent of the patients (1800 of 2668) had at least one of six co-morbid diseases and 45·6 per cent had an American Society of Anesthesiologists fitness grade of III or more. A total of 708 patients (26·5 per cent) died within 30 days of surgery. Every hour of delay from admission to surgery was associated with an adjusted 2·4 per cent decreased probability of survival compared with the previous hour (adjusted RR 1·024, 95 per cent c.i. 1·011 to 1·037). Conclusion: Limiting surgical delay in patients with PPU seems of paramount importance.

25 March 2011 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MMM. H. Møller
M. H. Møller
SAS. Adamsen
S. Adamsen
RTR. W. Thomsen
R. W. Thomsen
AMA. M. Møller
A. M. Møller

24 April 2015 in Critical Care
Verified
Journal Article
Open access
PDF file
SOSisse Rye Ostrowski
Sisse Rye Ostrowski
NHNicolai Haase
Nicolai Haase
RMRasmus Beier Müller
Rasmus Beier Müller
MMMorten Hylander Møller
Morten Hylander Møller
FPFrank Christian Pott
Frank Christian Pott
PJPär Ingemar Johansson
Pär Ingemar Johansson
Introduction: Patients with severe sepsis often present with concurrent coagulopathy, microcirculatory failure and evidence of vascular endothelial activation and damage. Given the critical role of the endothelium in balancing hemostasis, we investigated single-point associations between whole blood coagulopathy by thrombelastography (TEG) and plasma/serum markers of endothelial activation and damage in patients with severe sepsis. Methods: A post-hoc multicenter prospective observational study in a subgroup of 184 patients from the Scandinavian Starch for Severe Sepsis/Septic Shock (6S) Trial. Study patients were admitted to two Danish intensive care units. Inclusion criteria were severe sepsis, pre-intervention whole blood TEG measurement and a plasma/serum research sample available from baseline (pre-intervention) for analysis of endothelial-derived biomarkers. Endothelial-derived biomarkers were measured in plasma/serum by enzyme-linked immunosorbent assay (syndecan-1, thrombomodulin, protein C (PC), tissue-type plasminogen activator and plasminogen activator inhibitor-1). Pre-intervention TEG, functional fibrinogen (FF) and laboratory and clinical data, including mortality, were retrieved from the trial database. Results: Most patients presented with septic shock (86%) and pulmonary (60%) or abdominal (30%) focus of infection. The median (IQR) age was 67 years (59 to 75), and 55% were males. The median SOFA and SAPS II scores were 8 (6 to 10) and 56 (41 to 68), respectively, with 7-, 28- and 90-day mortality rates being 21%, 39% and 53%, respectively. Pre-intervention (before treatment with different fluids), TEG reaction (R)-time, angle and maximum amplitude (MA) and FF MA all correlated with syndecan-1, thrombomodulin and PC levels. By multivariate linear regression analyses, higher syndecan-1 and lower PC were independently associated with TEG and FF hypocoagulability at the same time-point: 100 ng/ml higher syndecan-1 predicted 0.64 minutes higher R-time (SE 0.25), 1.78 mm lower TEG MA (SE 0.87) and 0.84 mm lower FF MA (SE 0.42; all P <0.05), and 10% lower protein C predicted 1.24 mm lower TEG MA (SE 0.31). Conclusions: In our cohort of patients with severe sepsis, higher circulating levels of biomarkers of mainly endothelial damage were independently associated with hypocoagulability assessed by TEG and FF. Endothelial damage is intimately linked to coagulopathy in severe sepsis. Trial registration: Clinicaltrials.gov number: NCT00962156. Registered 13 July 2009.

19 October 2013 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MKMette Krag
Mette Krag
APAnders Perner
Anders Perner
JWJørn Wetterslev
Jørn Wetterslev
MWMatt P. Wise
Matt P. Wise
MMMorten Hylander Møller
Morten Hylander Møller